-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QgMQKg9lbQH/PlHW+055KUgK8xrI2FdugAQie3tXLxyJLAdVDnZgIeP5bzaj0yZU vDMzDMd8b7dz+H1/U31bAw== 0000950152-08-000094.txt : 20080107 0000950152-08-000094.hdr.sgml : 20080107 20080107164604 ACCESSION NUMBER: 0000950152-08-000094 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080107 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement FILED AS OF DATE: 20080107 DATE AS OF CHANGE: 20080107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 08515611 BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 8-K 1 l29442ae8vk.htm MYLAN INC. 8-K Mylan Inc. 8-K
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 7, 2008
MYLAN INC.
(Exact name of registrant as specified in its charter)
         
Pennsylvania   1-9114   25-1211621
(State or other jurisdiction
of Incorporation) 		  (Commission File
Number) 		  (I.R.S. Employer
Identification No.)
1500 Corporate Drive
Canonsburg, PA 15317
(Address of principal executive offices)
(724) 514-1800
(Registrant’s telephone number, including area code)
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
     o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
 
 

 

 

Item 1.01. Entry into a Material Definitive Agreement.
     On December 31, 2007, Mylan Inc., a Pennsylvania corporation (the “Company”), entered into an agreement (the “Agreement”) with N. Prasad, a member of its Board of Directors, MP Laboratories (Mauritius) Ltd, a subsidiary of the Company, and G2 Corporate Services Limited, an affiliate of Mr. Prasad. The agreement terminates Mr. Prasad’s employment relationship with the Company (and its January 8, 2007 Executive Employment Agreement and Transition and Succession Agreement with him) and appoints Mr. Prasad as a consultant to the Company, for a three-year term (subject to mutual agreement to extend the term). The Agreement sets forth the terms of the consultancy (including a monthly fee of $20,833.33 payable to Mr. Prasad) and also amends the Shareholders Agreement between the parties to extend by one year the term during which Mr. Prasad and his affiliates will continue to hold shares of Matrix Laboratories Limited and to vote such shares in accordance with the Company’s directions (in each case subject to the exceptions set forth in the Shareholders Agreement). The foregoing summary is qualified in its entirety by reference to the Agreement.
Item 1.02. Termination of a Material Definitive Agreement.
     As described in Item 1.01 above, the Executive Employment Agreement and Transition and Succession Agreement, in each case by and between the Company and Mr. Prasad and dated as of January 8, 2007, terminated on December 31, 2007, upon Mr. Prasad’s transition to service as a consultant for the Company.
SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
           
    MYLAN INC.
 
        
 
        
Date: January 7, 2008
  By:   /s/ Edward J. Borkowski
 
       
 
      Edward J. Borkowski
Executive Vice President and
Chief Financial Officer

 

-----END PRIVACY-ENHANCED MESSAGE-----